Brian J. Caveney
Known title: EVP, President of DiagnosticsCIK: 0001717915
Brian J. Caveney's purchase track record
Brian J. Caveney has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/7/2022 | LH | $10K | +1.1% | -0.3% | +0.3% |
| 6/7/2022 | LH | $10K | -7.6% | -4.1% | -5.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| LH | ▲ Buy | Grant | 9,304 | $0 | 3/26/2026 | View on chart |
| LH | ▼ Sell | Tax Withholding | 4,042 | $1.1M | 3/26/2026 | View on chart |
| LH | ▲ Buy | Grant | 1,986 | $0 | 3/26/2026 | View on chart |
| LH | ▼ Sell | Tax Withholding | 863 | $232K | 3/26/2026 | View on chart |
| LH | ▼ Sell | Open Market | 1,500 | $429K | 2/24/2026 | View on chart |
| LH | ▲ Buy | Option Exercise | 740 | — | 2/11/2026 | View on chart |
| LH | ▼ Sell | Tax Withholding | 211 | $61K | 2/11/2026 | View on chart |
| LH | ▼ Sell | Tax Withholding | 148 | $41K | 2/9/2026 | View on chart |
| LH | ▼ Sell | Tax Withholding | 32 | $9K | 2/9/2026 | View on chart |
| LH | ▲ Buy | Option Exercise | 517 | — | 2/7/2026 | View on chart |
| LH | ▲ Buy | Option Exercise | 111 | — | 2/7/2026 | View on chart |
| LH | ▲ Buy | Option Exercise | 670 | — | 2/6/2026 | View on chart |
| LH | ▼ Sell | Tax Withholding | 209 | $58K | 2/6/2026 | View on chart |
| LH | ▼ Sell | Open Market | 2,000 | $494K | 6/3/2025 | View on chart |
| LH | ▲ Buy | Grant | 4,840 | $0 | 3/27/2025 | View on chart |
| LH | ▼ Sell | Tax Withholding | 2,109 | $489K | 3/27/2025 | View on chart |
| LH | ▼ Sell | Tax Withholding | 136 | $33K | 2/11/2025 | View on chart |
| LH | ▲ Buy | Option Exercise | 473 | — | 2/11/2025 | View on chart |
| LH | ▼ Sell | Tax Withholding | 149 | $37K | 2/7/2025 | View on chart |
| LH | ▲ Buy | Option Exercise | 517 | — | 2/7/2025 | View on chart |
| LH | ▲ Buy | Option Exercise | 112 | — | 2/7/2025 | View on chart |
| LH | ▼ Sell | Tax Withholding | 33 | $8K | 2/7/2025 | View on chart |
| LH | ▲ Buy | Option Exercise | 670 | — | 2/6/2025 | View on chart |
| LH | ▼ Sell | Tax Withholding | 212 | $53K | 2/6/2025 | View on chart |
| LH | ▼ Sell | Tax Withholding | 5,061 | $1.1M | 3/27/2024 | View on chart |
| LH | ▲ Buy | Option Exercise | 11,556 | — | 3/27/2024 | View on chart |
| LH | ▼ Sell | Tax Withholding | 137 | $31K | 2/12/2024 | View on chart |
| LH | ▲ Buy | Option Exercise | 472 | — | 2/11/2024 | View on chart |
| LH | ▲ Buy | Option Exercise | 517 | — | 2/7/2024 | View on chart |
| LH | ▼ Sell | Tax Withholding | 171 | $38K | 2/7/2024 | View on chart |
| LH | ▲ Buy | Option Exercise | 112 | — | 2/7/2024 | View on chart |
| LH | ▼ Sell | Tax Withholding | 33 | $7K | 2/7/2024 | View on chart |
| LH | ▼ Sell | Tax Withholding | 166 | $37K | 2/2/2024 | View on chart |
| LH | ▲ Buy | Option Exercise | 495 | — | 2/2/2024 | View on chart |
| LH | ▼ Sell | Tax Withholding | 2,990 | $672K | 3/30/2023 | View on chart |
| LH | ▲ Buy | Grant | 6,763 | $0 | 3/30/2023 | View on chart |
| LH | ▼ Sell | Tax Withholding | 124 | $31K | 2/13/2023 | View on chart |
| LH | ▲ Buy | Option Exercise | 423 | — | 2/11/2023 | View on chart |
| LH | ▼ Sell | Tax Withholding | 164 | $40K | 2/6/2023 | View on chart |
| LH | ▲ Buy | Option Exercise | 560 | — | 2/4/2023 | View on chart |
| LH | ▲ Buy | Option Exercise | 443 | — | 2/2/2023 | View on chart |
| LH | ▼ Sell | Tax Withholding | 144 | $37K | 2/2/2023 | View on chart |
| LH | ▼ Sell | Tax Withholding | 894 | $209K | 11/7/2022 | View on chart |
| LH | ▲ Buy | Option Exercise | 2,010 | — | 11/5/2022 | View on chart |
| LH | ▲ Buy | Open Market | 44 | $10K | 9/7/2022 | View on chart |
| LH | ▲ Buy | Open Market | 42 | $10K | 6/7/2022 | View on chart |
| LH | ▼ Sell | Tax Withholding | 1,883 | $520K | 3/28/2022 | View on chart |
| LH | ▲ Buy | Grant | 4,241 | $0 | 3/27/2022 | View on chart |
| LH | ▼ Sell | Tax Withholding | 694 | $189K | 2/14/2022 | View on chart |
| LH | ▼ Sell | Tax Withholding | 84 | $23K | 2/14/2022 | View on chart |
| LH | ▲ Buy | Option Exercise | 284 | — | 2/12/2022 | View on chart |
| LH | ▲ Buy | Option Exercise | 2,354 | — | 2/12/2022 | View on chart |
| LH | ▲ Buy | Option Exercise | 560 | — | 2/4/2022 | View on chart |
| LH | ▼ Sell | Tax Withholding | 165 | $46K | 2/4/2022 | View on chart |
| LH | ▼ Sell | Tax Withholding | 147 | $40K | 2/2/2022 | View on chart |
| LH | ▲ Buy | Option Exercise | 443 | — | 2/2/2022 | View on chart |
| LH | ▲ Buy | Option Exercise | 2,010 | — | 11/5/2021 | View on chart |
| LH | ▼ Sell | Tax Withholding | 899 | $247K | 11/5/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Labcorp to Acquire OPKO Health's BioReference Assets for $722M
Labcorp has agreed to acquire select assets from OPKO Health's BioReference division for $722 million. This move expands Labcorp's capabilities in the diagnostics sector, a key area for the company's growth. The stock is currently trading near its 52-week high, reflecting investor interest in this strategic acquisition.
Labcorp to Acquire OPKO Health's BioReference Assets for $722M. Labcorp has agreed to acquire select assets from OPKO Health's BioReference division for $722 million. This move expands Labcorp's capabilities in the diagnostics sector, a key area for the company's growth. The stock is currently trading near its 52-week high, reflecting investor interest in this strategic acquisition.